News

Industry leaders gathered to address the current landscape of data collection in clinical trials.

Collaboration to focus on enhancing physician engagement in clinical trials and cancer research.

The ACT EU initiative aims to develop the European Union further as a competitive center for innovative clinical research.

Treatment facility to be the first to evaluate Deltacel for patients with non-small cell lung cancer.

Collaboration to focus on enabling clinicians to open clinical trials at the point of care.

Partnership enables Moderna to leverage Caris' library of de-identified, multi-modal data and analytics.

Company to integrate European diversity data from the UK and demographics data from France and Spain.

New hires expected to reinforce the company's clinical and digital trial expertise.

Move marks commitment to leading the frontier of AI-driven innovation and simulation in life sciences, company says.

Service expected to offer insights to sponsors conducting clinical trials in any indication in under ten days.

Added feature offers cost savings and the ability to reduce carbon footprint, company says.

CRO commits to achieving Net-Zero Standard by 2035.

Aims to advance innovative treatments for rare diseases.

Companies to collaborate on facilitating clinical trials in historically underserved regions.

Study focused on the impact of several socioeconomic factors, such as insurance coverage and patients' willingness to travel.

Patient organizations gave $22 billion in grants for research, patient services, and access to care over the last five years, says report.

Since the inception of their partnership in 2008, Medidata and the NCI have collaborated across thousands of clinical trials.

Pharma company is the second to join the project.

New module designed to provide simple storage of participant consent.

VaxTRIALS adds a new Latin America base and greater vaccine research depth.

GenosAI, embedded into H1's clinical trial intelligence platform, Trial Landscape, can analyze and respond to complex inquiries.

Developed with industry stakeholders, Longboat v2.2 provides patients with access to their study information in one site-focused solution.

Collaboration to focus on accelerating clinical development and increase access to research.

Company intends to expand AI and predictive clinical trial intelligence throughout the Asia-Pacific region.

New clinical research approach aims to accelerate and streamline clinical development for emerging biopharm organizations.

Company can now incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform.

Ronco is a global pharmaceutical executive with experience in a number of R&D leadership positions over more than two decades.

Bingham discusses the logistical challenges associated with coordinating patient involvement in rare disease clinical trials.